ArticleNeurosurgical review2026
Etiological analysis and reoperative strategies for recurrent or failed hemifacial spasm after microvascular decompression.
Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To systematically analyze the etiologies underlying recurrent or failed symptoms after microvascular decompression (MVD) for primary hemifacial spasm (HFS) and to evaluate the safety and efficacy of a tailored reoperative strategy based on precise etiological classification. A retrospective analysis was conducted on 72 patients who experienced recurrence or failure after MVD, all treated by the same surgeon between January 2009 and December 2025. Based on intraoperative findings during revision surgery, the causes were classified into four types: Type I (missed offending vessel), Type II (vessel migration or inadequate decompression), Type III (Teflon-related complications: adhesion/compression), and Type IV (misidentification of anatomical structures in the initial surgery). Individualized reoperations were performed according to the specific etiology. Among 72 patients, 51 had recurrent symptoms and 21 had persistent symptoms. The etiological distribution was: Type I, 15 cases (20.8%); Type II, 34 cases (47.2%); Type III, 17 cases (23.6%); and Type IV, 6 cases (8.3%). After reoperation, 70 patients (97.2%) were cured, while 2 remained symptomatic. Complications included early and delayed facial palsy (20 cases), hearing loss or tinnitus (7 cases), lower cranial nerve injury (3 cases), hydrocephalus (2 cases), and delayed intracranial hemorrhage (1 case). Failure after MVD is a multifactorial outcome that can be systematically categorized into four main types. A reoperative strategy guided by this etiological classification significantly enhances treatment specificity and success rates. Although associated with a higher risk of complications than primary surgery, this approach is overall safe and effective, providing a reliable solution for this clinical challenge.
Indexed as
Identifiers
42702634What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.